- Home
- DBX vs RGEN Comparison
DBX vs RGEN Comparison
Compare DBX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBX
- RGEN
- Stock Information
- Founded
- DBX 2007
- RGEN 1981
- Country
- DBX United States
- RGEN United States
- Employees
- DBX N/A
- RGEN N/A
- Industry
- DBX Computer Software: Prepackaged Software
- RGEN Medical/Dental Instruments
- Sector
- DBX Technology
- RGEN Health Care
- Exchange
- DBX Nasdaq
- RGEN Nasdaq
- Market Cap
- DBX 8.2B
- RGEN 7.4B
- IPO Year
- DBX 2018
- RGEN N/A
- Fundamental
- Price
- DBX $29.46
- RGEN $123.24
- Analyst Decision
- DBX Buy
- RGEN Buy
- Analyst Count
- DBX 4
- RGEN 12
- Target Price
- DBX $30.00
- RGEN $172.67
- AVG Volume (30 Days)
- DBX 3.4M
- RGEN 844.5K
- Earning Date
- DBX 05-08-2025
- RGEN 04-29-2025
- Dividend Yield
- DBX N/A
- RGEN N/A
- EPS Growth
- DBX N/A
- RGEN N/A
- EPS
- DBX 1.48
- RGEN N/A
- Revenue
- DBX $2,541,600,000.00
- RGEN $650,429,000.00
- Revenue This Year
- DBX N/A
- RGEN $12.61
- Revenue Next Year
- DBX N/A
- RGEN $15.24
- P/E Ratio
- DBX $19.82
- RGEN N/A
- Revenue Growth
- DBX 0.79
- RGEN 4.88
- 52 Week Low
- DBX $20.68
- RGEN $102.97
- 52 Week High
- DBX $33.33
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- DBX 63.93
- RGEN 39.31
- Support Level
- DBX $28.31
- RGEN $125.31
- Resistance Level
- DBX $29.27
- RGEN $143.56
- Average True Range (ATR)
- DBX 0.73
- RGEN 6.86
- MACD
- DBX 0.15
- RGEN -1.22
- Stochastic Oscillator
- DBX 75.07
- RGEN 0.54
About DBX Dropbox Inc.
Dropbox provides cloud storage and content collaboration tools, focusing on individuals and small to midsize businesses. Founded in 2007, Dropbox was a pioneer in the file sync and share market. In recent years, the firm has been emphasizing its Dash product, which facilitates AI-powered universal search across unstructured cloud data.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.